Increased ratio of anti-apoptotic to pro-apoptotic Bcl2 gene-family members in lithium-responders one month after treatment initiation.
about
Second messenger/signal transduction pathways in major mood disorders: moving from membrane to mechanism of action, part II: bipolar disorderDiscovery and validation of blood biomarkers for suicidalityMolecular actions and clinical pharmacogenetics of lithium therapyThe elements of life and medicinesLithium protects against paraquat neurotoxicity by NRF2 activation and miR-34a inhibition in SH-SY5Y cells.Biomarkers for Psychiatry: The Journey from Fantasy to Fact, a Report of the 2013 CINP Think TankA balanced translocation disrupting BCL2L10 and PNLDC1 segregates with affective psychosisPharmacogenomics of bipolar disorder.Coding and noncoding gene expression biomarkers in mood disorders and schizophrenia.Transcriptome sequencing implicates dorsal striatum-specific gene network, immune response and energy metabolism pathways in bipolar disorder.Dysplasticity, metaplasticity, and schizophrenia: Implications for risk, illness, and novel interventions.Potential application of lithium in Parkinson's and other neurodegenerative diseases.Lithium-responsive genes and gene networks in bipolar disorder patient-derived lymphoblastoid cell lines.Effects of Lithium Monotherapy for Bipolar Disorder on Gene Expression in Peripheral LymphocytesLithium-induced neuroprotection is associated with epigenetic modification of specific BDNF gene promoter and altered expression of apoptotic-regulatory proteinsErythropoietin improved cognitive function and decreased hippocampal caspase activity in rat pups after traumatic brain injury.Possible beneficial effects of lithium chloride on cerulein-induced acute pancreatitis in mice.Gene-expression differences in peripheral blood between lithium responders and non-responders in the Lithium Treatment-Moderate dose Use Study (LiTMUS).Supplementation with spermine during in vitro maturation of porcine oocytes improves early embryonic development after parthenogenetic activation and somatic cell nuclear transfer.From direct to indirect lithium targets: a comprehensive review of omics data.Lithium response viewed as a biomarker to predict developmental psychopathology in offspring with bipolar disorder: a commentary.Distinct lithium-induced gene expression effects in lymphoblastoid cell lines from patients with bipolar disorder.CDK inhibitor SU9516 induces tetraploid blastocyst formation from parthenogenetically activated porcine embryos.The observed alteration in BCL2 expression following lithium treatment is influenced by the choice of normalization method.A gene co-expression module implicating the mitochondrial electron transport chain is associated with long-term response to lithium treatment in bipolar affective disorder
P2860
Q27002419-E58052DF-23C2-4954-BBE7-F0564E09332CQ28296874-6A2C8DB6-0BB7-47AB-8D67-A6166D754BC0Q28307770-3D507E72-05AE-47EB-9D1A-59DF7400CD3AQ28649323-D00128C7-B055-4198-88AD-9FF567388CC7Q35657214-6FCB518E-C3BE-4099-843A-AB0F83F01147Q36287896-7A597F4F-BEA4-4F7E-BFC0-493E70438D14Q37717836-6683F445-90CF-44C7-888B-0C98551B4643Q38097534-363E39BA-9E47-4F3E-8239-FB570B44C739Q38156156-1D9ABE47-C5C2-494C-A48C-9AC8D1156711Q38437361-EAAD5733-BD1A-41DB-9DBE-435252A77698Q38495807-0235947E-81C4-4B44-A04B-4AFF8BAF85CEQ38636753-CBF6DC3D-1FAA-48C6-BC67-A72157386F80Q38758778-EB216BBB-2256-4F7B-8001-F12ADEF106C4Q41653853-A0994245-B3F2-4CDF-8869-D9A8B462DAA4Q41862498-7AC5AC2A-83AC-460C-BBDD-0D9D1BFB6937Q41950510-DE8549C9-6E68-4E0F-80E8-A2A3A7CA5073Q43124083-8A89B18F-BEC1-4E5B-9245-B3AF91CDD433Q45053879-266195C4-92DC-4C32-8C1A-B3A5936053E6Q46565891-DBDEB080-AC88-4697-871D-52140BEC0C95Q47779120-8433BE4B-99B9-4379-8DBE-193A0AA680CAQ48406708-8110B6A9-01D8-4FB4-8857-D02A65C467C3Q49916344-C80EAF49-47D3-478D-8B9F-92C7213ECAECQ50450208-AB57BBA8-D30A-4D21-B82C-4D32A04CDCD8Q55262536-A9A05024-635C-400B-AC28-EEBD2F2D006EQ57077038-815AD442-7662-4DDF-BBB1-67B93852CA11
P2860
Increased ratio of anti-apoptotic to pro-apoptotic Bcl2 gene-family members in lithium-responders one month after treatment initiation.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Increased ratio of anti-apopto ...... th after treatment initiation.
@ast
Increased ratio of anti-apopto ...... th after treatment initiation.
@en
type
label
Increased ratio of anti-apopto ...... th after treatment initiation.
@ast
Increased ratio of anti-apopto ...... th after treatment initiation.
@en
prefLabel
Increased ratio of anti-apopto ...... th after treatment initiation.
@ast
Increased ratio of anti-apopto ...... th after treatment initiation.
@en
P2093
P2860
P356
P1476
Increased ratio of anti-apopto ...... th after treatment initiation.
@en
P2093
Aiping Lin
Anjana Muralidharan
Boris Lorberg
Hongyu Zhao
Janine Leffert
Kathleen Maloney
Lori Lowthert
Rajita Sinha
Robert Beech
Sheila Umlauf
P2860
P2888
P356
10.1186/2045-5380-2-15
P577
2012-09-12T00:00:00Z
P5875
P6179
1010615515